“I was keen to go on a clinical trial. I wanted to try new cancer treatments and hopefully help future generations.”
A trial to evaluate an age extension to the NHS Breast Screening Programme
This trial is looking at the risks or benefits of extending the age when women are invited for breast screening.
More about this trial
At present, all women between the ages of 50 and 70 are invited for breast screening as part of the NHS Breast Screening Programme (NHSBSP). In this trial the age range is being extended to include women between the ages of 47 and 49 and 71 to 73. Researchers hope to learn the risks and benefits of inviting women in these age ranges for additional screening.
The age extension to the NHSBSP (AgeX) is taking place in 65 Breast Screening Units across England. During the study, half the women between the ages of 47 to 49, and half the women between the ages of 71 to 73 will be
Researchers will collect information about the number of women who are diagnosed with breast cancer and the number of women who die of the disease.
The aim of this study is to see if extending the age range of breast screening reduces deaths from breast cancer.
More information about this study is available on www.agex.uk.
Who can enter
You may be invited to enter this study if you
- Are female and aged between 47 and 49 or between 71 and 73
- Live in an area where the breast screening unit is involved in the study
This study is taking place at 65 Breast Screening Units in England. In these areas:
- half the women between the ages of 47 and 49 will receive an invite for screening and the other half will not
- half the women between the ages of 71 and 73 will receive an invite, and the other half will not. Some women between the ages of 74 and 79 who have previously been invited, may also be invited for an extra screen
It is a randomised study. Women are put into groups by a computer. You cannot decide which group you are in. Women over 70 can ask to have breast screening every 3 years wherever they live.
If you receive an invite and decide to attend for screening, you will have at least 1 extra visit to the screening unit.
Although having an extra
We have more information about having a mammogram.
How to join a clinical trial
Professor Julietta Patnick
Public Health England
NHS Breast Screening Programme
University of Oxford
Cancer Research UK